Skip to main content

Articles

Page 2 of 60

  1. Originally designed as anti-hyperglycemic drugs, Glucagon-Like Peptide-1 receptor agonists (GLP-1Ra) and Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated protective cardiovascular effects, ...

    Authors: Angelica Cersosimo, Nadia Salerno, Jolanda Sabatino, Alessandra Scatteia, Giandomenico Bisaccia, Salvatore De Rosa, Santo Dellegrottaglie, Chiara Bucciarelli-Ducci, Daniele Torella and Isabella Leo
    Citation: Cardiovascular Diabetology 2024 23:94
    Content type: Review Published on:

  2. Research on identifiable risks for metabolic syndrome (MetS) is ongoing, and growing evidence suggests that bilirubin is a potent antioxidant and cytoprotective agent against MetS. Ho...

    Authors: Ae Hee Kim, Da-Hye Son, Mid-Eum Moon, Soyoung Jeon, Hye Sun Lee and Yong-Jae Lee
    Citation: Cardiovascular Diabetology 2024 23:92
    Content type: Research Published on:

  3. Recent guidelines propose N-terminal pro-B-type natriuretic peptide (NT-proBNP) for recognition of asymptomatic left ventricular (LV) dysfunction (Stage B Heart Failure, SBHF) in type 2 diabetes mellitus (T2DM...

    Authors: Cheng Hwee Soh, Alex G. C. de Sá, Elizabeth Potter, Amera Halabi, David B. Ascher and Thomas H. Marwick
    Citation: Cardiovascular Diabetology 2024 23:91
    Content type: Research Published on:

  4. Atrial fibrillation (AF) has been linked to an increased risk of cardiovascular death, overall mortality and heart failure in patients with type 2 diabetes mellitus (T2DM). The present study investigated the a...

    Authors: Xue-Ming Li, Wei-Feng Yan, Ke Shi, Rui Shi, Li Jiang, Yue Gao, Chen-Yan Min, Xiao-Jing Liu, Ying-Kun Guo and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2024 23:90
    Content type: Research Published on:

  5. Platelets play an important role in the development of cardiovascular disease (CVD). Mean platelet volume (MPV) is considered as biological marker of platelets activity and function. The aim of the present stu...

    Authors: Velia Cassano, Giuseppe Armentaro, Domenico Iembo, Sofia Miceli, Teresa V. Fiorentino, Elena Succurro, Maria Perticone, Franco Arturi, Marta L. Hribal, Tiziana Montalcini, Francesco Andreozzi, Giorgio Sesti, Arturo Pujia and Angela Sciacqua
    Citation: Cardiovascular Diabetology 2024 23:89
    Content type: Research Published on:

  6. Type-2 diabetes (T2D) worsens stroke recovery, amplifying post-stroke disabilities. Currently, there are no therapies targeting this important clinical problem. Sodium-glucose cotransporter 2 inhibitors (SGLT2...

    Authors: Ellen Vercalsteren, Dimitra Karampatsi, Carolina Buizza, Thomas Nyström, Thomas Klein, Gesine Paul, Cesare Patrone and Vladimer Darsalia
    Citation: Cardiovascular Diabetology 2024 23:88
    Content type: Research Published on:

  7. Insulin resistance (IR) is involved in the pathophysiological processes of arrhythmias. Increasing evidence suggests triglyceride and glucose (TyG) index, metabolic score for insulin resistance (METS-IR), trig...

    Authors: Zhe Wang, Haoming He, Yingying Xie, Jiaju Li, Fangyuan Luo, Zhaowei Sun, Shuwen Zheng, Furong Yang, Xuexi Li, Xiaojie Chen, Yingwei Chen and Yihong Sun
    Citation: Cardiovascular Diabetology 2024 23:87
    Content type: Research Published on:

  8. Studies on the relationship between insulin resistance (IR) surrogates and long-term all-cause mortality in patients with coronary heart disease (CHD) and hypertension are lacking. This study aimed to explore ...

    Authors: Xin-Zheng Hou, Yan-Fei Lv, Yu-Shan Li, Qian Wu, Qian-Yu Lv, Ying-Tian Yang, Lan-Lan Li, Xue-Jiao Ye, Chen-Yan Yang, Man-Shi Wang, Lin-Lin Cao and Shi-Han Wang
    Citation: Cardiovascular Diabetology 2024 23:86
    Content type: Research Published on:

  9. Non-alcoholic fatty liver disease (NAFLD), identified by the Fatty Liver Index (FLI), is associated with increased mortality and cardiovascular (CV) outcomes. Whether this also applies to type 1 diabetes (T1D)...

    Authors: Monia Garofolo, Daniela Lucchesi, Massimo Giambalvo, Michele Aragona, Alessandra Bertolotto, Fabrizio Campi, Cristina Bianchi, Paolo Francesconi, Piero Marchetti, Stefano Del Prato and Giuseppe Penno
    Citation: Cardiovascular Diabetology 2024 23:85
    Content type: Research Published on:

  10. The Stress hyperglycemia ratio (SHR) is a novel marker reflecting the true acute hyperglycemia status and is associated with clinical adverse events. The relationship between SHR and mortality in patients with...

    Authors: Lei Ding, Hongda Zhang, Cong Dai, Aikai Zhang, Fengyuan Yu, Lijie Mi, Yingjie Qi and Min Tang
    Citation: Cardiovascular Diabetology 2024 23:84
    Content type: Research Published on:

  11. Whether distributions and prognostic values of high-sensitivity cardiac troponin (hs-cTn) T and I are different across normoglycemic, prediabetic, and diabetic populations is unknown.

    Authors: Jiajun Zhang, Xiaoxing Li, Shenglin Zhang, Zhen Wang, Rui Tian, Feng Xu, Yuguo Chen and Chuanbao Li
    Citation: Cardiovascular Diabetology 2024 23:83
    Content type: Research Published on:

  12. Intensive glycemic control reduced coronary artery disease (CAD) events among the Action to Control Cardiovascular Disease Risk in Diabetes (ACCORD) participants with the haptoglobin (Hp) 2-2 phenotype only. I...

    Authors: Rachel A. Warren, Michael P. Bancks, Allie S. Carew, Andrew P. Levy, John Sapp, Judy Bahnson, Cora E. Lewis, Eric B. Rimm, Mark A. Espeland and Leah E. Cahill
    Citation: Cardiovascular Diabetology 2024 23:82
    Content type: Research Published on:

  13. Current literature is deficient in robust evidence delineating the correlation between the triglyceride glucose-body mass index (TyG-BMI) and the incidence of stroke. Consequently, this investigation seeks to ...

    Authors: Yuankai Shao, Haofei Hu, Qiming Li, Changchun Cao, Dehong Liu and Yong Han
    Citation: Cardiovascular Diabetology 2024 23:81
    Content type: Research Published on:

  14. This study aimed to evaluate the association of triglyceride-glucose (TyG) index with all-cause and cardiovascular mortality risk among patients with cardiometabolic syndrome (CMS).

    Authors: Quanjun Liu, Yeshen Zhang, Shuhua Chen, Hong Xiang, Jie Ouyang, Huiqin Liu, Jing Zhang, Yanfei Chai, Zishun Zhan, Peng Gao, Xiao Zhang, Jianing Fan, Xinru Zheng, Zhihui Zhang and Hongwei Lu
    Citation: Cardiovascular Diabetology 2024 23:80
    Content type: Research Published on:

  15. Insulin resistance (IR) is associated with coronary artery disease (CAD) severity. However, its underlying mechanisms are not fully understood. Therefore, our study aimed to explore the relationship between IR...

    Authors: Tingjie Yang, Guoyong Li, Che Wang, Guian Xu, Qingman Li, Yapan Yang, Lijie Zhu, Lulin Chen, Xueqing Li and Honghui Yang
    Citation: Cardiovascular Diabetology 2024 23:79
    Content type: Research Published on:

  16. We aimed to assess the effect of SGLT2i on arrhythmias by conducting a meta-analysis using data from randomized controlled trials(RCTs).

    Authors: Jia Liao, Ramin Ebrahimi, Zhiyu Ling, Christian Meyer, Martin Martinek, Philipp Sommer, Piotr Futyma, Davide Di Vece, Alexandra Schratter, Willem-Jan Acou, Lin Zhu, Márcio G. Kiuchi, Shaowen Liu, Yuehui Yin, Helmut Pürerfellner, Christian Templin…
    Citation: Cardiovascular Diabetology 2024 23:78
    Content type: Research Published on:

  17. The atherogenic index of plasma (AIP) has been demonstrated to be significantly associated with the incidence of prediabetes and diabetes. This study aimed to investigate the association between the AIP and u...

    Authors: Shuwan Xu, Jun Liu, Dong Zhao, Na Yang, Yongchen Hao, Yan Zhou, Dan Zhu and Ming Cui
    Citation: Cardiovascular Diabetology 2024 23:77
    Content type: Research Published on:

  18. The triglyceride-glucose (TyG) index is considered a dependable biomarker for gauging insulin resistance. The atherogenic index of plasma (AIP) represents a marker reflecting atherosclerosis. However, there is...

    Authors: Xiaosheng Wu, Weiping Qiu, Huancheng Yang, Yan-Jun Chen, Jianling Liu and Guojun Zhao
    Citation: Cardiovascular Diabetology 2024 23:76
    Content type: Research Published on:

  19. Early since the onset of the COVID-19 pandemic, the medical and scientific community were aware of extra respiratory actions of SARS-CoV-2 infection. Endothelitis, hypercoagulation, and hypofibrinolysis were i...

    Authors: Inés Valencia, Jairo Lumpuy-Castillo, Giselle Magalhaes, Carlos F. Sánchez-Ferrer, Óscar Lorenzo and Concepción Peiró
    Citation: Cardiovascular Diabetology 2024 23:75
    Content type: Review Published on:

  20. Authors: Monica Gamez, Hesham E. Elhegni, Sarah Fawaz, Kwan Ho Ho, Neill W. Campbell, David A. Copland, Karen L. Onions, Matthew J. Butler, Elizabeth J. Wasson, Michael Crompton, Raina D. Ramnath, Yan Qiu, Yu Yamaguchi, Kenton P. Arkill, David O. Bates, Jeremy E. Turnbull…
    Citation: Cardiovascular Diabetology 2024 23:74
    Content type: Correction Published on:

    The original article was published in Cardiovascular Diabetology 2024 23:50

  21. Stress hyperglycemia ratio (SHR) has recently been recognized as a novel biomarker that accurately reflects acute hyperglycemia status and is associated with poor prognosis of heart failure. We evaluated the r...

    Authors: Xiangming Hu, Dejing Feng, Yuxuan Zhang, Can Wang, Yang Chen, Guannan Niu, Zheng Zhou, Zhenyan Zhao, Hongliang Zhang, Moyang Wang and Yongjian Wu
    Citation: Cardiovascular Diabetology 2024 23:73
    Content type: Research Published on:

  22. The 2022 Canadian Cardiovascular Society (CCS) cardiorenal guideline provided clinical recommendations on sodium-glucose co-transport 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1R...

    Authors: Muhammad Usman Ali, G. B. John Mancini, Donna Fitzpatrick-Lewis, Kim A. Connelly, Eileen O’Meara, Shelley Zieroth and Diana Sherifali
    Citation: Cardiovascular Diabetology 2024 23:72
    Content type: Review Published on:

  23. We assessed the efficacy and safety of enavogliflozin (0.3 mg), a newly developed SGLT-2 inhibitor, in patients with type 2 diabetes mellitus based on kidney function via pooled analysis of two 24-week, random...

    Authors: Young Sang Lyu, Sangmo Hong, Si Eun Lee, Bo Young Cho and Cheol-Young Park
    Citation: Cardiovascular Diabetology 2024 23:71
    Content type: Research Published on:

  24. Angiogenin, an enzyme belonging to the ribonucleases A superfamily, plays an important role in vascular biology. Here, we sought to study the association of plasma angiogenin and major adverse cardiovascular e...

    Authors: Resham L. Gurung, Sylvia Liu, Jian-Jun Liu, Yiamunaa M., Huili Zheng, Clara Chan, Keven Ang, Tavintharan Subramaniam, Chee Fang Sum and Su Chi Lim
    Citation: Cardiovascular Diabetology 2024 23:70
    Content type: Research Published on:

  25. Studies have demonstrated that coronary artery calcification on one hand and non-alcoholic fatty liver disease (NAFLD) on the other hand are strongly associated with cardiovascular events. However, it remains ...

    Authors: Damien Denimal, Maharajah Ponnaiah, Anne-Caroline Jeannin, Franck Phan, Agnès Hartemann, Samia Boussouar, Etienne Charpentier, Alban Redheuil, Fabienne Foufelle and Olivier Bourron
    Citation: Cardiovascular Diabetology 2024 23:69
    Content type: Research Published on:

  26. Gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (T2DM) share many pathophysiological factors including genetics, but whether epigenetic marks are shared is unknown. We aimed to test whether a ...

    Authors: Teresa M. Linares-Pineda, Nicolas Fragoso-Bargas, María José Picón, Maria Molina-Vega, Anne Karen Jenum, Line Sletner, Sindre Lee-Ødegård, Julia O. Opsahl, Gunn-Helen Moen, Elisabeth Qvigstad, Rashmi B. Prasad, Kåre I. Birkeland, Sonsoles Morcillo and Christine Sommer
    Citation: Cardiovascular Diabetology 2024 23:68
    Content type: Research Published on:

  27. Recent studies highlighted that stress hyperglycemia ratio (SHR) is a potential predictor for future risk in heart failure (HF) patients. However, its implications specifically in HF with preserved ejection fr...

    Authors: Abdul-Quddus Mohammed, Yongqiang Luo, Kaitao Wang, Yang Su, Lu Liu, Guoqing Yin, Wen Zhang, J Jiasuer. Alifu, Redhwan M. Mareai, Ayman A. Mohammed, Yawei Xu, Fuad A. Abdu and Wenliang Che
    Citation: Cardiovascular Diabetology 2024 23:67
    Content type: Research Published on:

  28. The triglyceride glucose (TyG) index is a new and low-cost marker to determine insulin resistant which may be a predictor of cardiovascular disease (CVD). Although available evidence showed that its associatio...

    Authors: Ghazaal Alavi Tabatabaei, Noushin Mohammadifard, Hamed Rafiee, Fatemeh Nouri, Asieh Maghami mehr, Jamshid Najafian, Masoumeh Sadeghi, Maryam Boshtam, Hamidreza Roohafza, Fahimeh Haghighatdoost, Marzieh Taheri and Nizal Sarrafzadegan
    Citation: Cardiovascular Diabetology 2024 23:66
    Content type: Research Published on:

  29. Heart failure (HF) is increasing at an alarming rate, primary due to the rising in aging, obesity and diabetes. Notably, individuals with type 1 diabetes (T1D) face a significantly elevated risk of HF, leading...

    Authors: María Teresa Julián, Alejandra Pérez-Montes de Oca, Josep Julve and Nuria Alonso
    Citation: Cardiovascular Diabetology 2024 23:65
    Content type: Review Published on:

  30. The TyG-BMI index, which is a reliable indicator of insulin resistance (IR), has been found to have a significant correlation with the occurrence of cardiovascular events. However, there still lacks study on t...

    Authors: Yi Hu, Yiting Zhao, Jing Zhang and Chaomin Li
    Citation: Cardiovascular Diabetology 2024 23:64
    Content type: Research Published on:

  31. Metabolic syndrome is characterized as the co-occurrence of interrelated cardiovascular risk factors, including insulin resistance, hyperinsulinemia, abdominal obesity, dyslipidemia and hypertension. Once week...

    Authors: Stephen J. Nicholls, Santiago Tofé, Carel W. le Roux, David A. D’Alessio, Russell J. Wiese, Imre Pavo, Katelyn Brown, Govinda J. Weerakkody, Meltem Zeytinoglu and Irene C. Romera
    Citation: Cardiovascular Diabetology 2024 23:63
    Content type: Research Published on:

  32. Currently, the differentiation between type 1 diabetes (T1D) and type 2 diabetes (T2D) is not straightforward, and the features of both types of diabetes coexist in one subject. This situation triggered the ne...

    Authors: Weronika Bielka, Agnieszka Przezak, Piotr Molęda, Ewa Pius-Sadowska and Bogusław Machaliński
    Citation: Cardiovascular Diabetology 2024 23:62
    Content type: Review Published on:

  33. Stress hyperglycemia and glycemic variability (GV) can reflect dramatic increases and acute fluctuations in blood glucose, which are associated with adverse cardiovascular events. This study aimed to explore w...

    Authors: Hao-ming He, Shu-wen Zheng, Ying-ying Xie, Zhe Wang, Si-qi Jiao, Fu-rong Yang, Xue-xi Li, Jie Li and Yi-hong Sun
    Citation: Cardiovascular Diabetology 2024 23:61
    Content type: Research Published on:

  34. Coronary microvascular dysfunction (CMD) is a frequent complication of diabetes mellitus (DM) characterized by challenges in both diagnosis and intervention. Circulating levels of microRNAs are increasingly re...

    Authors: Yihai Liu, Chongxia Zhong, Shan Chen, Yanan Xue, Zhonghai Wei, Li Dong and Lina Kang
    Citation: Cardiovascular Diabetology 2024 23:60
    Content type: Research Published on:

  35. The stress hyperglycaemic ratio (SHR), a new marker that reflects the true hyperglycaemic state of patients with acute coronary syndrome (ACS), is strongly associated with adverse clinical outcomes in these pa...

    Authors: Kui Li, Xueyuan Yang, Yunhang Li, Guanxue Xu and Yi Ma
    Citation: Cardiovascular Diabetology 2024 23:59
    Content type: Research Published on:

  36. Patients with diabetes mellitus have poor prognosis after myocardial ischemic injury. However, the mechanism is unclear and there are no related therapies. We aimed to identify regulators of diabetic myocardia...

    Authors: Yunhui Lv, Kai Li, Shuo Wang, Xiaokang Wang, Guangxin Yue, Yangyang Zhang, Xin Lv, Ping Zhao, Shiping Wang, Qi Zhang, Qiuju Li, Jinyan Zhu, Jubo Li, Peng Peng, Yue Li, Jiafei Luo…
    Citation: Cardiovascular Diabetology 2024 23:58
    Content type: Research Published on:

  37. No randomized clinical trials have directly compared the cardiorenal effectiveness of empagliflozin and GLP-1RA agents with demonstrated cardioprotective effects in patients with a broad spectrum of cardiovasc...

    Authors: Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik and Elisabetta Patorno
    Citation: Cardiovascular Diabetology 2024 23:57
    Content type: Research Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2024 23:103

  38. SGLT2 inhibitors and DPP4 inhibitors have been suggested to affect lipid metabolism. However, there are few randomized controlled trials comparing the effects on the lipid metabolism between the two types of a...

    Authors: Mototsugu Nagao, Jun Sasaki, Kyoko Tanimura-Inagaki, Ichiro Sakuma, Hitoshi Sugihara and Shinichi Oikawa
    Citation: Cardiovascular Diabetology 2024 23:56
    Content type: Research Published on:

  39. Hypoglycaemia has been shown to induce a systemic pro-inflammatory response, which may be driven, in part, by the adrenaline response. Prior exposure to hypoglycaemia attenuates counterregulatory hormone respo...

    Authors: Clementine E. M. Verhulst, Julia I. P. van Heck, Therese W. Fabricius, Rinke Stienstra, Steven Teerenstra, Rory J. McCrimmon, Cees J. Tack, Ulrik Pedersen-Bjergaard and Bastiaan E. de Galan
    Citation: Cardiovascular Diabetology 2024 23:55
    Content type: Research Published on:

  40. The atherogenic index of plasma (AIP) and cardiovascular disease (CVD) in participants with abnormal glucose metabolism have been linked in previous studies. However, it was unclear whether AIP control level a...

    Authors: Qianqian Min, Zhigang Wu, Jiangnan Yao, Siyi Wang, Lanzhi Duan, Sijia Liu, Mei Zhang, Yanhong Luo, Dongmei Ye, Yuxu Huang, Lan Chen, Ke Xu and Jianghua Zhou
    Citation: Cardiovascular Diabetology 2024 23:54
    Content type: Research Published on:

  41. Coronary heart disease (CHD) is a major global health concern, especially among individuals with type 2 diabetes (T2D). Given the crucial role of proteins in various biological processes, this study aimed to e...

    Authors: Hong Luo, Marie-Theres Huemer, Agnese Petrera, Stefanie M. Hauck, Wolfgang Rathmann, Christian Herder, Wolfgang Koenig, Annika Hoyer, Annette Peters and Barbara Thorand
    Citation: Cardiovascular Diabetology 2024 23:53
    Content type: Research Published on:

  42. The outcomes of percutaneous coronary intervention (PCI) in diabetic patients are still suboptimal, and it is unclear if diabetic patients might derive a benefit from the use of drug-coated balloons.

    Authors: Gianluca Caiazzo, Angelo Oliva, Luca Testa, Tay M. Heang, Chuey Y. Lee, Diego Milazzo, Giulio Stefanini, Nicola Pesenti, Antonio Mangieri, Antonio Colombo and Bernardo Cortese
    Citation: Cardiovascular Diabetology 2024 23:52
    Content type: Research Published on:

  43. It has been confirmed that the ApoB/ApoA1 ratio is closely associated with the incidence of cardiometabolic diseases (CMD). However, due to uncontrolled confounding factors in observational studies, the causal...

    Authors: Chao Fu, Dongbo Liu, Qi Liu, Xuedong Wang, Xiaoxue Ma, Hong Pan, Shi Feng, Zhao Sun, Weishen Qiao, Mengyue Yang, Shuang Gao, Hongyu Ding, Xingtao Huang and Jingbo Hou
    Citation: Cardiovascular Diabetology 2024 23:51
    Content type: Research Published on:

  44. Diabetes mellitus is a chronic disease which is detrimental to cardiovascular health, often leading to secondary microvascular complications, with huge global health implications. Therapeutic interventions tha...

    Authors: Monica Gamez, Hesham E. Elhegni, Sarah Fawaz, Kwan Ho Ho, Neill W. Campbell, David A. Copland, Karen L. Onions, Matthew J. Butler, Elizabeth J. Wasson, Michael Crompton, Raina D. Ramnath, Yan Qiu, Yu Yamaguchi, Kenton P. Arkill, David O. Bates, Jeremy E. Turnbull…
    Citation: Cardiovascular Diabetology 2024 23:50
    Content type: Research Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2024 23:74

  45. Diabetic cardiomyopathy (DbCM) is a form of Stage B heart failure (HF) at high risk for progression to overt disease. Using baseline characteristics of study participants from the Aldose Reductase Inhibition f...

    Authors: James L. Januzzi, Stefano Del Prato, Julio Rosenstock, Javed Butler, Justin Ezekowitz, Nasrien E. Ibrahim, Carolyn S.P. Lam, Thomas Marwick, W. H. Wilson Tang, Yuxi Liu, Reza Mohebi, Alessia Urbinati, Faiez Zannad and Riccardo Perfetti
    Citation: Cardiovascular Diabetology 2024 23:49
    Content type: Research Published on:

  46. The impact of the coexistence of type 2 diabetes mellitus (T2DM) in patients with non-ischemic dilated cardiomyopathy (DCM) on clinical profiles, myocardial fibrosis, and outcomes remain incompletely understood.

    Authors: Yangjie Li, Hong Xian, Yuanwei Xu, Weihao Li, Jiajun Guo, Ke Wan, Jie Wang, Ziqian Xu, Qing Zhang, Yuchi Han, Jiayu Sun and Yucheng Chen
    Citation: Cardiovascular Diabetology 2024 23:48
    Content type: Research Published on:

  48. Underweight imposes significant burden on cardiovascular outcomes in patients with diabetes mellitus. However, less is known about the impact of serial change in body weight status measured as body mass index ...

    Authors: Joo Hee Jeong, Yun Gi Kim, Kyung-Do Han, Seung-Young Roh, Hyoung Seok Lee, Yun Young Choi, Jaemin Shim, Jong-Il Choi and Young-Hoon Kim
    Citation: Cardiovascular Diabetology 2024 23:46
    Content type: Research Published on:

  49. The prognostic value of triglyceride-glucose (TyG) index in general type 2 diabetes mellitus (T2DM) patients is still unclear. Therefore, we aimed to determine the associations between TyG and all-cause/cause-...

    Authors: Younan Yao, Bo Wang, Tian Geng, Jiyan Chen, Wan Chen and Liwen Li
    Citation: Cardiovascular Diabetology 2024 23:43
    Content type: Research Published on:

  50. Asialoglycoprotein receptor 1 (ASGR1), primarily expressed on hepatocytes, promotes the clearance and the degradation of glycoproteins, including lipoproteins, from the circulation. In humans, loss-of-function...

    Authors: Monika Svecla, Lorenzo Da Dalt, Annalisa Moregola, Jasmine Nour, Andrea Baragetti, Patrizia Uboldi, Elena Donetti, Lorenzo Arnaboldi, Giangiacomo Beretta, Fabrizia Bonacina and Giuseppe Danilo Norata
    Citation: Cardiovascular Diabetology 2024 23:42
    Content type: Research Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions 

Cardiovascular Diabetology

ISSN: 1475-2840